COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

differentiating between malignant and vaccine-related lymphadenopathy

7 COVID vaccine complications: The radiologist's role in identifying adverse reactions

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

long covid brainstem damage

Ultra-high field MRI implicates long COVID in brainstem damage

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

Thumbnail

MRI study pinpoints neural roots of lingering fatigue post-COVID infection

Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated. 

Thumbnail

MRI findings linked to cognitive issues in patients with long COVID 2 years post-infection

The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.

COVID-19 coronavirus mask smell

Loss of smell during COVID linked to structural, functional brain alterations

According to data shared by the CDC last year, around 34% of patients who contracted COVID between 2020 and 2023 reported losing their sense of smell. 

phenylephrine FDA

COVID remnants still show up on PET/CT scans years after infection

That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.

Imaging study reveals 'significant deformities' in lungs of some COVID patients

These changes could have long-lasting implications for lung function, authors of the new study warn.

Thumbnail

Even two years after recovery, damage to multiple regions of the brain persists in COVID patients

On imaging some former COVID patients show significant alterations in several parts of the brain related to emotional regulation.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.